Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

 
ORIGINAL ARTICLE
Ahead of print publication  

Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer


1 Department of Medical Biotechnology, School of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
2 Department of Medical Biotechnology, School of Allied Medicine; Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran
3 Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran
4 Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, Iran
5 Department of Anesthetic, School of Allied Medicine, Qazvin University of Medical Sciences, Qazvin, Iran

Correspondence Address:
Reza Nekouian,
Department of Medical Biotechnology, School of Allied Medicine, Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jcrt.JCRT_592_17

 > Abstract 


Introduction: Gastric cancer is responsible for a large number of death worldwide and its high death rate is associated with a lack of noninvasive tools in GC diagnosis. MicroRNAs (miRNAs), as gene regulators, were shown to dysregulate in different types of cancer. Moreover, it is proven that miRNAs are stable in serum/plasma, so they can be used as a potential noninvasive marker in GC diagnosis. The objective of this study is to investigate the plasma miRNA expression in GC samples compared to controls as a potential biomarker in cancer diagnosis.
Materials and Methods: Expression levels of miR-21 and miR-222 were assessed using quantitative real-time polymerase chain reaction in plasma of 30 GC patients and 30 healthy controls. Diagnostic value of selected miRNAs was evaluated using receiver operating characteristic curve. Target prediction was done using bioinformatics tools to investigate the signaling pathways and function of the selected miRNAs.
Results: Our results demonstrated that the expression levels of miR-21 and miR-222 were significantly higher in GC plasma than in the controls (P < 0.0001, P = 0.043). The sensitivity and specificity for miR-21 and in plasma were 86.7% and 72.2% and for miR-222 were 62.5% and 56.2%, respectively. Bioinformatics analysis revealed that most target genes of miR-21 and miR-222 are involved in cancer-related signaling pathway such as tumor initiation and progression.
Conclusion: Our results indicated that miR-21 and miR-222 in plasma samples can be served as a potential noninvasive tool in GC detection. Furthermore, the miRNA target prediction manifested that miR-21 and miR-222 involve in key processes associated with GC initiation and development.

Keywords: Biomarker, diagnosis, gastric cancer, microRNA, plasma



How to cite this URL:
Emami SS, Nekouian R, Akbari A, Faraji A, Abbasi V, Agah S. Evaluation of circulating miR-21 and miR-222 as diagnostic biomarkers for gastric cancer. J Can Res Ther [Epub ahead of print] [cited 2019 Jan 20]. Available from: http://www.cancerjournal.net/preprintarticle.asp?id=244469

.






 

 
Top
 
 
  Search
 
     Search Pubmed for
 
    -  Emami SS
    -  Nekouian R
    -  Akbari A
    -  Faraji A
    -  Abbasi V
    -  Agah S
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  >Abstract
  In this article

 Article Access Statistics
    Viewed201    
    PDF Downloaded7    

Recommend this journal